Promethium Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Buy
8,728
+2,000
+30% +$231K 0.55% 52
2025
Q4
$714K Hold
6,728
0.39% 64
2025
Q3
$570K Hold
6,728
0.33% 71
2025
Q2
$538K Sell
6,728
-1,640
-20% -$130K 0.33% 72
2025
Q1
$758K Sell
8,368
-379
-4% -$35.4K 0.49% 55
2024
Q4
$877K Sell
8,747
-141
-2% -$14.5K 0.6% 49
2024
Q3
$1.02M Buy
+8,888
New +$1.06M 0.72% 42

Other funds holding MRK

Promethium Advisors's MRK Position: Q1 2026 in Review

Promethium Advisors increased its Merck (MRK) stake by 30% in Q1 2026, buying an estimated $231K and bringing the position to 8,728 shares worth $1.06M. The position accounts for 0.55% of the portfolio, ranked #52.

Promethium Advisors first reported a position in MRK in Q3 2024 and has held it in 7 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Promethium Advisors held 8,728 shares of Merck worth $1.06M as of Q1 2026.
  • Promethium Advisors bought 2,000 Merck shares in Q1 2026, an estimated $231K.
  • Merck made up 0.55% of Promethium Advisors's portfolio in Q1 2026, its #52 holding.
  • Promethium Advisors first reported a position in Merck in Q3 2024 and has held it in 7 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Promethium Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.